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Background and aims: Advanced glycation end products (AGEs) are toxic compounds involved 
in the onset of insulin resistance in obesity. In particular, AGEs are preferentially trapped by 
adipose tissue through the binding with the AGE-receptor RAGE, leading to the activation of 
proinflammatory signalling in adipocytes that can interfere with peripheral insulin sensitivity. 
The genetically-induced deletion of RAGE in leptin receptor deleted (DbDb) mice, a model of type 
2 diabetes/obesity, is reported to prevent AGEs trapping in adipocytes, paralleled by increased 
circulating levels of AGEs, and reduced adipose tissue inflammation and insulin resistance. Since 
this might increase the exposition to AGEs of highly perfused organs, such as the liver, we aimed 
to analyze whether the deletion of RAGE affected hepatic AGEs accumulation and detoxification in 
the liver of obese/diabetic animals.  
Materials and methods: At 13 weeks of age, wild-type C57, DbDb and DbDb RAGE-/- mice were 
sacrificed, plasma was collected and liver was removed. Gene and protein expression of AGEs 
receptors and detoxifying systems were analyzed in parallel to hepatic AGEs content, activation of 
lipogenesis, and markers of inflammation. 
Results: The deletion of RAGE in the liver of DbDb mice was associated with decreased 
expression of AGE-receptor-1 (P<0.05 vs. DbDb) and reduced expression and activity of 
glyoxalase-1 (P<0.01 vs. DbDb), two major AGEs detoxifying systems, and increased galectin-3 
expression (P<0.05 vs. DbDb), another AGEs-receptor. The latter may be a compensatory 
response to remove plasma AGEs. Thus, despite the lacking of RAGE, high levels of intrahepatic 
AGEs were maintained in DbDb RAGE-/- mice, due to either the trapping exerted by galectin-3 
and/or the reduced potential of detoxifying systems. These alterations were also associated to 
persistent activation of the SREBP1c lipogenic pathway (P<0.001 vs. C57), and the 
proinflammatory NLRP3 signaling pathway (P<0.05 vs. C57), that were not prevented by RAGE 
deletion compared to DbDb mice. 
Conclusion: RAGE deletion in the liver of an animal model of type 2 diabetes influences other 
AGE-receptors and AGE-detoxifying systems. In particular, the increase in galectin-3 in DbDb 
RAGE-/- mice liver might be responsible for the sustained hepatosteatosis and inflammation. This  
complex mechanism of control should be taken into account when investigating on the pathogenic 
contribution of AGEs to hepatic obesity/diabetes complications. 
